Biotechnology Value Fund L P - Nov 6, 2025 SCHEDULE 13D/A Report for MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX)

Filing Manager: BIOTECHNOLOGY VALUE FUND L P
Reporting Manager: BVF PARTNERS L P/IL
Security: MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share
Symbol: MLTX
Shares outstanding: 71.3M shares
Disclosed Ownership: 19.8M shares
Ownership: 27.7%
Form type: SCHEDULE 13D/A
Date filed: 11/10/2025, 05:27 PM
Date of event: Nov 6, 2025
SEC: View on sec.gov

Reporting Managers (11)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BIOTECHNOLOGY VALUE FUND L P	14.3%	10.2M	0	10.2M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0000918923
BVF I GP LLC	14.3%	10.2M	0	10.2M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001803805
BIOTECHNOLOGY VALUE FUND II LP	11.4%	8.17M	0	8.17M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001102444
BVF II GP LLC	11.4%	8.17M	0	8.17M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001803806
Biotechnology Value Trading Fund OS LP	1.8%	1.29M	0	1.29M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001660683
BVF Partners OS Ltd.	1.8%	1.29M	0	1.29M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001660684
BVF GP HOLDINGS LLC	25.8%	18.4M	0	18.4M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001803809
BVF PARTNERS L P/IL	27.7%	19.8M	0	19.8M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001055947
BVF INC/IL	27.7%	19.8M	0	19.8M	/s/ Mark N. Lampert	Mark N. Lampert, Authorized Signatory	0001056807
LAMPERT MARK N	27.7%	19.8M	0	19.8M	/s/ Mark N. Lampert	Mark N. Lampert	0001233840
Loy Spike	0.03%	19K	19K	0	/s/ Spike Loy	Spike Loy	0001920549